HEPATIC STEATOSIS
Clinical trials for HEPATIC STEATOSIS explained in plain language.
Never miss a new study
Get alerted when new HEPATIC STEATOSIS trials appear
Sign up with your email to follow new studies for HEPATIC STEATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Daily shot aims to shrink dangerous liver fat
Disease control Recruiting nowThis study is testing whether a daily injection called tesamorelin can reduce fat buildup in the liver of adults with fatty liver disease. 120 participants will receive either the active drug or a placebo injection for one year, with both groups receiving lifestyle advice. The ma…
Matched conditions: HEPATIC STEATOSIS
Phase: PHASE2 • Sponsor: Hudson Biotech • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
Cheaper scan for fatty liver disease? new study puts ultrasound to the test
Diagnosis Recruiting nowThis study is testing a new type of ultrasound scan, called DeepUSFF, to see if it can accurately measure fat in the liver. Researchers will compare the results from this new ultrasound to the results from a more expensive and less available MRI scan, which is currently a top met…
Matched conditions: HEPATIC STEATOSIS
Phase: NA • Sponsor: Seoul National University Hospital • Aim: Diagnosis
Last updated Apr 02, 2026 14:57 UTC
-
Researchers track hidden liver damage in HIV patients
Knowledge-focused Recruiting nowThis study aims to understand and predict the risk of fatty liver disease and liver scarring in people living with HIV. Researchers will follow 320 HIV-positive participants for five years, using special scans and blood tests to track liver health. The goal is to create better to…
Matched conditions: HEPATIC STEATOSIS
Sponsor: Shanghai Public Health Clinical Center • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:43 UTC